The risk of atherosclerosis in patients with impaired glucose tolerance

Research Communications in Molecular Pathology and Pharmacology

Volumn 113-114, Issue , 2003, Pages 87-95

  Okopien, Boguslaw ^a   Stachura Kulach, A ^a   Kulach, A ^a   Kowalski, J ^a   Zielinski, M ^a   Wisniewska Wanat, M ^a   Sierant, M ^a   Kalina, Z ^a   Stanislaw Herman, Z ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Atherosclerotic injury; Coagulation fibrinolysis disturbances; Dyslipidemia; Glucose metabolism disorders; Hyperinsulinemia; Impaired Glucose Tolerance (IGT); Insulin resistance; Monocyte adhesion; Monocyte Chemoattractant Peptide (MCP); Patients

Indexed keywords

APOLIPOPROTEIN; CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DYSLIPIDEMIA; ENDOTHELIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBRINOLYSIS; GLUCOSE METABOLISM; HUMAN; HYPERINSULINEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MONOCYTE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

ADULT; ARTERIOSCLEROSIS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCOSE METABOLISM DISORDERS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPOPROTEINS, LDL; MIDDLE AGED; MONOCYTE CHEMOATTRACTANT PROTEINS; PLASMINOGEN ACTIVATOR INHIBITOR 1; RISK FACTORS;

EID: 13144249151     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Cirino, G., Napoli, C., Bucci, M., Cicala C. (2000). Inflammation - coagulation network: are serine protease receptors the knot? Trends Pharmacol. Sci. 21: 170-172.
2. Festa, A., D'Agostino, R., Mykkanen, L., Tracy, R., Howard, B.V., Haffner, S.M. (1999). Low-density lipoprotein particle size is inversely related to plasminogen activator inhibitor-1 levels. The Insulin Resistance Atherosclerosis Study. Arterioscler. Thromb. Vasc. Biol. 19: 605-610.
3. Hanefeld, M., Temelkova-Kurktschiev, T., Schaper, F., Henkel, E., Siegert, G., Koehler, C. (1999). Impaired Fasting Glucose is not a risk factor for atherosclerosis. Diabet. Med. 16: 212-218.
4. Henkel, E., Koehler, C., Temelkova-Kurktschiev, T., Hanefeld, M. (2002). Prediktoren von Glukosetoleranzstorungen in einer Rizikopopulation fur Typ-2-Diabetes: Die RIAD studie. Dtsch. Med. Wohenschr. 127: 953-957.
5. Howard, G., O'Leary, D.H., Zaccaro, D., Haffner, S., Rewers, M., Hamman, R., Selby, J.V., Saad, M.F., Savage, P., Bergman, R. (1996). Insulin sensitivity and atherosclerosis. The Insulin Resistance and Atherosclerosis Study (IRAS) Investigators. Circulation. 93: 1809-1817.
6. Hsueh, W., Law, R.E. (1999). Insulin signaling in the arterial wall. Am. J. Cardiol. 84: 21J-24J.
7. Hulthe, J., Fagerberg, B. (2002). Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study). Atheroscler. Thromb. Vasc. Biol. 22: 1162-1167.
8. Koehler, C., Temelkova-Kurktschiev, T., Schaper, F., Fucker, K., Hanefeld, M. (1999). Pravalenz von neuentdecktem Typ-2-Diabetes, gestorter Glukosetoleranz und gestorter Nuchternglukoze in einer Rizikopopulation. Daten der RIAD studie nach Anwendung neuer Diagnosekriterien fur Diabetes. Dtsch. Med. Wohenschr. 124: 1057-1061.
9. Kowalski, J., Okopien, B., Madej, A., Makowiecka, K., Zielinski, M., Kalina, Z., Herman, Z.S. (2001). Levels of sICAM-1, sVCAM-1 and MCP-1 in patients with hyperlipoproteinemia IIa and IIb. Int. J. Clin. Pharmacol. Ther. 39: 48-52.
10. Laakso, M., Lehto, S. (1998). Epidemiology of risk factors for cardiovascular disease in diabetes and Impaired Glucose Tolerance. Atherosclerosis. 137: s65-s73.
11. Mukaida, N., Harada, A., Matsushima, K. (1998). Interleukin-8 and monocyte chemotactic activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions. Cytokine Grow Factor Rev. 9: 9-23.
12. Nagi, D.K., Mohamed-Ali, V., Jain, S.K., Walji, S., Yudkin, J.S. (1996). Plasminogen Activator Inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin dependent diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians. Diabet. Med. 13: 59-64.
13. Okopien, B., Cwalina, L., Lebek, M., Kowalski, J., Zielinski, M., Wisniewska-Wanat, M., Kalina, Z., Herman, Z.S. (2001). Effects of fibrates on plasma prothrombotic activity in patients with Type IIb dyslipidemia. Int. J. Clin. Pharmacol. Ther. 12: 551-557.
14. Ravandi, A., Kuksis, A., Shaikh, N.A. (2000). Glucosylated glycerophosphoethanolamines are the major LDL glycation products and increase LDL susceptibility to oxidation: evidence of their presence in atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 20: 467-477
15. Ross, R. (1999). Atherosclerosis - an inflammatory disease. N. Eng. J. Med. 340: 115-126.
16. Sobal, G., Menzel, J., Sinzinger, H. (2000). Why is glycated LDL more sensitive to oxidation than native LDL? A comparative study. Prostaglandins Leukot. Essent. Fatty Acids 63: 177-186.
17. Sonoco, K., Yoshinari, M., Iwase, M., Iino, K., Ichikawa, K., Ohdo, S., Higuchi, S., Iida, M. (2002). Glycoxidized low-density lipoprotein enhances monocyte chemo attractant protein-1 mRNA expression in human umbilical vein endothelial cells. Metabolism 51: 1135-1142.
18. Temelkova-Kurktschiev, T., Siegert, G., Bergmann, S., Henkel, E., Koehler, C., Jaross, W., Hanefeld, M. (2002). Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes. Metabolism 51: 743-749.
19. Temelkova-Kurktschiev, T., Henkel, E., Schaper, F., Koehler, C., Siegert, G., Hanefeld, M. (2000). Prevalence and atherosclerosis risk in different types of non-diabetic hyperglycemia. Is mild hyperglycemia an underestimated evil? Exp. Clin. Endocrinol. Diabetes 108: 93-99.
20. Watanabe, N., Taniguchi, T., Taketoh, H., Kitagawa, Y., Namura, H., Yoneda, N., Kurimoto, Y., Yamada, S., Ishikawa, Y. (1999). Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients. Diabetes Care 22: 152-156.